Brain oxygen levels during heart valve replacement
Part of Heart & circulation clinical trials.
This study measures oxygen levels in the brain during a minimally invasive heart valve replacement procedure (TAVI) to understand how the brain is affected during the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe narrowing of your aortic heart valve.
- You are experiencing symptoms like shortness of breath or chest pain due to the valve problem.
- You are scheduled to have a TAVI procedure.
- You do not have active brain disorders, significant carotid artery disease, or other serious conditions listed by the doctors.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with aortic stenosis who are getting a TAVI valve replacement. It uses imaging tests (MRI and CT) to learn more about the condition and improve future care.
This study looks at how replacing a narrowed heart valve affects fluid in the lungs. It may help doctors better understand recovery after this procedure.
This study checks whether special heart tests can better understand “in-between” blocked heart arteries before and after TAVI (a valve replacement done through a catheter). It may help doctors choose the safest, most accurate treatment when coronary artery disease is unclear.
This trial looks at how the heart's electrical system may change after TAVI, a procedure to replace a narrowed aortic valve. It aims to better understand these changes to improve care for future patients.
This study is testing a new way to monitor blood flow and heart function during a valve replacement procedure. It may help doctors track how well the heart is pumping.
This trial tests whether giving a high dose of a statin (atorvastatin) before and during a heart valve replacement procedure (TAVR) can reduce the risk of brain injury. Statins are cholesterol-lowering drugs that may also protect the brain, and this study aims to see if they help people undergoing TAVR.
Hear when a new Aortic Stenosis Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.